Recognizing hemophilia in its latent form
Stakovetskaia, Z.S.
Vrachebnoe Delo 5: 105-107
1972
ISSN/ISBN: 0049-6804 PMID: 5029774 Document Number: 49520
Document emailed within 1 workday
Related Documents
Shulga, I.D.; Belinskaia, L.P.; Shapkin, E.I.; Prilipskaia, N.I.; Semidotskaia, Z.D. 1978: Latent form of glomerulonephritis Klinicheskaia Meditsina 56(8): 27-32Kopanev, V.I. 1970: Latent form of vertigo Voenno-Meditsinskii Zhurnal 10: 62-64
Mazurin, A.V.; Iakunina, L.N.; Plakhuta, T.G. 1978: "Inhibitory" form of hemophilia in children Problemy Gematologii i Perelivaniia Krovi 7: 18-21
Chernov, N.N. 1986: Latent form of glutathione reductase in the rat liver Biokhimiia 51(5): 762-769
Lutze, G.; Schlote, A.; Beyer, H.; Kropf, S. 1985: Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(16): 479-483
Markarian, S.S.; Sidel'nikov, I.A. 1974: Determination of the latent form of vestibulo-autonomic instability under hypoxic conditions Zdravookhranenie Rossiiskoi Federatsii 5: 17-21
Simon, G.C. 1970: Latent cancer of the cecum revealed by acute appendicitis of occlusive form La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 46(41): 2622-2624
Sukhovyĭ, M.V.; Demydiuk, V.F.; Tomilin, V.V.; Vozniuk, V.P.; Aver'ianov, I.V.; Iushchenko, P.V.; Semeniaka, V.I.; Vdovtsov, O.A.; Burnaieva, S.V. 2002: Pathogenetic substantiation of the treatment of inhibitory form of hemophilia in patients in mandatory surgical intervention Klinichna Khirurhiia 8: 58-61
Sokolov, A.N.; Savchenko, V.G.; Trakhtenberg, A.K.; Andreev, I.N.; Tochenov, A.V.; Isaev, V.G.; Skidan, N.I.; Chemis, A.G.; Vishnevskaia, E.S.; Togonidze, D.K. 2001: Effective combined treatment of thymus carcinoma with complete eradication of tumor after neoadjuvant therapy in a patient with severe form of hemophilia a Terapevticheskii Arkhiv 73(7): 70-72
Silver, M.R.; ole-MoiYoi, O.; Austen, K.F.; Spragg, J. 1980: Active site radioimmunoassay for human urokallikrein and demonstration by radioimmunoassay of a latent form of the enzyme Journal of Immunology 124(4): 1551-1555
Lillicrap, D.P.; Bridge, P.J.; Giles, A.R. 1990: Organization of a hemophilia genetic screening program. Ontario Hemophilia Study Group Progress in Clinical and Biological Research 324: 19-28
Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Nichols, S.; Mahoney, E.M.; Sirois, P.A.; Bordeaux, J.D.; Stehbens, J.A.; Loveland, K.A.; Amodei, N. 2000: HIV-associated changes in adaptive, emotional, and behavioral functioning in children and adolescents with hemophilia: results from the Hemophilia Growth and Development Study Journal of Pediatric Psychology 25(8): 545-556
Vikhot', N.E.; Povolotskii, I.L. 1972: Activation of latent adenovirus infection of human tonsil cell cultures by superinfection with adenoviruses of the latent subgroup Voprosy Virusologii 17(6): 680-682
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Girolami, A.; Dal Bo Zanon, R.; Procidano, M. 1981: Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1 Folia Haematologica 108(6): 863-871
Jones, P. 1979: Organization of hemophilia therapy. the role of the hemophilia center Sangre 24(5-C): 998-1004
Magallón Martínez, M.; Ortega, F.; Pinilla, J. 1992: AIDS and hemophilia: experience in the La Paz Hemophilia Center Haemostasis 22(5): 281-292
Walker, I.; Poon, M.C. 1992: Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors Group Lancet 339(8784): 61-62